SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
0.4051
-0.0148 (-3.52%)
At close: Jun 27, 2025, 4:00 PM
0.4100
+0.0049 (1.21%)
After-hours: Jun 27, 2025, 7:59 PM EDT
SeaStar Medical Holding Revenue
SeaStar Medical Holding had revenue of $293.00K in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $428.00K. In the year 2024, SeaStar Medical Holding had annual revenue of $135.00K.
Revenue (ttm)
$428.00K
Revenue Growth
n/a
P/S Ratio
11.92
Revenue / Employee
$22,526
Employees
19
Market Cap
4.28M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 135.00K | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ICU News
- 3 days ago - SeaStar Medical Reports Update on Nasdaq Listing Status - GlobeNewsWire
- 4 days ago - SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy - GlobeNewsWire
- 8 days ago - SeaStar Medical Announces Pricing of Up to $8 Million Public Offering - GlobeNewsWire
- 17 days ago - AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research - GlobeNewsWire
- 4 weeks ago - SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy - GlobeNewsWire
- 6 weeks ago - SeaStar Medical Holding Corporation (ICU) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 6 weeks ago - SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury - GlobeNewsWire